课题基金 / 基金详情

PROTECTIVE TREATMENT FOR CATHETERS

PROTECTIVE TREATMENT FOR CATHETERS
导管的保护性处理
批准号:
3500953
负责人:
JOHN B NEWKIRK
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1988-04-14

项目摘要

项目成果

JOHN B NEWKIRK的其他基金

相关文献

中文摘要
翻译
长期目标: 使中心静脉导管(CVC)商业化 它们已经过化学处理以减少它们的倾向 引发感染,从而带来重大的人道主义利益 以及大幅降低医院护理成本。 具体目标和方法: (1)应用已经开发的抗菌工艺 硅橡胶对常用CVC的防护(希克曼) 设备; (2)确定抗微生物活性的持续时间和水平 在生理盐水灌流期间进行最佳处理的导管, 营养和肿瘤治疗解决方案; (3)确定处理过的导管的保护程度 通过上述(2)中使用的方法,在体外对抗管腔定植; (4)测定各处理组小鼠组织的生物相容性。 导管材料; (5)测定正常储藏对抗菌效果的影响 经处理的导管的活性和抗张强度。
英文摘要
Long Term Objective: To make commercially available central venous catheters (CVC) which have been chemically treated to reduce their tendency to induce infections thereby bringing major humanitarian benefits and substantial reductions in hospital care costs. Specific Aims and Methodology: (1) apply an already developed process for antimicrobial protection of silicone rubber to a commonly used CVC (Hickman) device; (2) determine the duration and levels of antimicrobial activity of optimally treated catheters during perfusion with saline, nutritional, and oncotherapeutic solutions; (3) determine the degrees of protection of treated catheters against lumen colonization in vitro, by methods used in (2) above; (4) determine the biocompatibility in mouse tissue of the treated catheter material; (5) determine the effects of normal storage on antibacterial activity and tensile strength of treated catheters.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
LateTIME:一项 II 期、随机、双盲、安慰剂对照试点试验,评估急性心肌梗塞后 2 至 3 周给予骨髓单核细胞的安全性和效果。
DOI: --
发表时间: 2010
期刊: Texas Heart Institute journal
影响因子: 0.9
作者: [Traverse,JayH, Henry,TimothyD, Vaughan,DouglasE, Ellis,StephenG, Pepine,CarlJ, Willerson,JamesT, Zhao,DavidXM, Simpson,LaraM, Penn,MarcS, Byrne,BarryJ, Perin,EmersonC, Gee,AdrianP, Hatzopoulos,AntonisK, McKenna,DavidH, Forder,]
通讯作者: Forder,
DOI: 10.1007/s11883-013-0341-9
发表时间: 2013-08
期刊: Current atherosclerosis reports
影响因子: 5.8
作者: [Szady AD, Pepine CJ, Sharma SV, Cogle CR, Perin EC, Ellis SG, Moyé LA, Cardiovascular Cell Therapy Research Network (CCTRN)]
通讯作者: Cardiovascular Cell Therapy Research Network (CCTRN)
DOI: 10.3109/14653240903511952
发表时间: 2010-05
期刊: Cytotherapy
影响因子: 4.5
作者: [Stroncek D, Berlyne D, Fox B, Gee A, Heimfeld S, Lindblad R, Loper K, McKenna D Jr, Rooney C, Sabatino M, Wagner E, Whiteside T, Wood D, Heath-Mondoro T]
通讯作者: Heath-Mondoro T
DOI: 10.1001/jama.2011.1670
发表时间: 2011-11-16
期刊: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
影响因子: 120.7
作者: [Traverse, Jay H., Henry, Timothy D., Ellis, Stephen G., Pepine, Carl J., Willerson, James T., Zhao, David X. M., Forder, John R., Byrne, Barry J., Hatzopoulos, Antonis K., Penn, Marc S., Perin, Emerson C., Baran, Kenneth W., Chambers, Jeffrey, Lambert, Charles, Raveendran, Ganesh, Simon, Daniel I., Vaughan, Douglas E., Simpson, Lara M., Gee, Adrian P., Taylor, Doris A., Cogle, Christopher R., Thomas, James D., Silva, Guilherme V., Jorgenson, Beth C., Olson, Rachel E., Bowman, Sherry, Francescon, Judy, Geither, Carrie, Handberg, Eileen, Smith, Deirdre X., Baraniuk, Sarah, Piller, Linda B., Loghin, Catalin, Aguilar, David, Richman, Sara, Zierold, Claudia, Bettencourt, Judy, Sayre, Shelly L., Vojvodic, Rachel W., Skarlatos, Sonia I., Gordon, David J., Ebert, Ray F., Kwak, Minjung, Moye, Lemuel A., Simari, Robert D.]
通讯作者: Simari, Robert D.
PROTECTIVE TREATMENT FOR POLYMERIC SOLIDS
  • 批准号:
    3508395
  • 项目类别:
  • 资助金额:
    $22.97万
  • 财政年份:
    1985
  • 负责人:
    JOHN B NEWKIRK
  • 依托单位:
PROTECTIVE TREATMENT FOR POLYMERIC SOLIDS
  • 批准号:
    3508396
  • 项目类别:
  • 资助金额:
    $21.06万
  • 财政年份:
    1985
  • 负责人:
    JOHN B NEWKIRK
  • 依托单位: